27378927|t|Anti-Inflammatory Properties of Menthol and Menthone in Schistosoma mansoni Infection
27378927|a|Schistosomiasis is a parasitic disease caused by several species of trematode worms and it is believed that more than 261 million people are affected worldwide. New drug development has become essential because there is a risk of the parasite becoming resistant to Praziquantel, the only drug available for this infection. This study evaluated parasitological, immunological and histological parameters in mice infected with Schistosoma mansoni and treated with an herbal commercial medicine. This drug consists of menthol (30-55%) and menthone (14-32%). A 60 day treatment regimen with the herbal medicine decreased the number of S. mansoni eggs in the feces, liver, and intestine and reduced the number of hepatic granulomas. We observed a reduction of 84% in blood eosinophilia and a decrease in the IL-4 and IL-10 blood levels after treatment. Therefore, we propose that schistosomiasis treatment with this herbal medicine for 60 days has an immunomodulatory and anti-inflammatory action in this animal model for schistosomiasis thus contributing to the decrease in physio pathological effects caused by S. mansoni infection.
27378927	0	28	Anti-Inflammatory Properties	T080	C1515999
27378927	32	39	Menthol	T109,T121	C0025368
27378927	44	52	Menthone	T109	C0065950
27378927	56	85	Schistosoma mansoni Infection	T047	C0036330
27378927	86	101	Schistosomiasis	T047	C0036323
27378927	107	124	parasitic disease	T047	C0030499
27378927	143	150	species	T185	C1705920
27378927	154	169	trematode worms	T204	C3662558
27378927	216	222	people	T098	C0027361
27378927	227	235	affected	T169	C0392760
27378927	251	267	drug development	T091	C0872152
27378927	279	288	essential	T080	C0205224
27378927	320	328	parasite	T204	C0030498
27378927	338	347	resistant	T039	C1514892
27378927	351	363	Praziquantel	T109,T121	C0032911
27378927	374	378	drug	T121	C0013227
27378927	398	407	infection	T046	C3714514
27378927	414	419	study	T062	C2603343
27378927	420	429	evaluated	T058	C0220825
27378927	430	445	parasitological	T080	C0205468
27378927	447	460	immunological	T169	C0205470
27378927	465	477	histological	T169	C0205462
27378927	478	488	parameters	T033	C0449381
27378927	492	496	mice	T015	C0025929
27378927	497	505	infected	T033	C0439663
27378927	511	530	Schistosoma mansoni	T204	C0036319
27378927	535	547	treated with	T061	C0332293
27378927	551	577	herbal commercial medicine	T121	C2240391
27378927	584	588	drug	T121	C0013227
27378927	601	608	menthol	T109,T121	C0025368
27378927	622	630	menthone	T109	C0065950
27378927	650	667	treatment regimen	T061	C0040808
27378927	677	692	herbal medicine	T121	C2240391
27378927	693	702	decreased	T081	C0205216
27378927	717	727	S. mansoni	T204	C0036319
27378927	728	732	eggs	T204	C0686887
27378927	740	745	feces	T031	C0015733
27378927	747	752	liver	T023	C0023884
27378927	758	767	intestine	T023	C0021853
27378927	772	779	reduced	T080	C0392756
27378927	794	812	hepatic granulomas	T047	C0745754
27378927	817	825	observed	T169	C1441672
27378927	828	837	reduction	T061	C0441610
27378927	848	866	blood eosinophilia	T047	C0014457
27378927	873	881	decrease	T081	C0205216
27378927	889	893	IL-4	T116,T129	C0021758
27378927	898	903	IL-10	T116,T129	C0085295
27378927	904	916	blood levels	T031	C0005768
27378927	923	932	treatment	T061	C0087111
27378927	961	976	schistosomiasis	T047	C0036323
27378927	977	986	treatment	T061	C0087111
27378927	997	1012	herbal medicine	T121	C2240391
27378927	1032	1048	immunomodulatory	T080	C0205556
27378927	1053	1077	anti-inflammatory action	T080	C1515999
27378927	1086	1098	animal model	T008	C0599779
27378927	1103	1118	schistosomiasis	T047	C0036323
27378927	1124	1136	contributing	T052	C1880177
27378927	1144	1152	decrease	T081	C0205216
27378927	1163	1175	pathological	T169	C1521733
27378927	1176	1183	effects	T080	C1280500
27378927	1194	1214	S. mansoni infection	T047	C0036330